Introduction: Coronary heart disease and hyperlipidemia is a global problem in today’s world. A large number of people suffer from hyperten-sion, atherosclerosis and all these has strong association with the hyperlipidemia. There are many drugs for the treatment of hyperlipidemia, but statins are most commonly used. But, with high dose of statins, the side effect is also there which restricts its use in high dose. Ezetimibe is a comparatively new drug for the treatment of hyperlipidemia having lesser adverse effect as compared to statin. This study has been planned to find out the comparative efficacy of Ezetimibe and Atorvastatin alone and in combination on the lipid profile in rats. Methodology: This study wa
BACKGROUND: Treatments with ezetimibe/simvastatin (combined or alone) have been indicated as very pr...
Introduction: Although statin therapy is a powerful lipid-lowering strategy, only one-fifth of stati...
PURPOSE: To explore the interaction between antiobesity drug, topiramate, and hypolipidemic drug, at...
Background Ezetimibe, as a cholesterol absorption inhibitor, has been shown protecting against ather...
Ezetimibe, as a cholesterol absorption inhibitor, has been shown protecting against atherosclerosis ...
Ezetimibe, as a cholesterol absorption inhibitor, has been shown protecting against atherosclerosis ...
Background: Many patients on statin therapy do not achieve recommended LDL cholesterol goals. They r...
Background: Dyslipidemia is a major cause of atherosclerosis and atherosclerosis induced conditions....
Patients with dyslipoproteinemia constitute the largest risk group for development of atherosclerosi...
Introduction: Although statin therapy is a powerful lipid-lowering strategy, only one-fifth of stati...
SummaryBackgroundOxidized low-density lipoprotein (LDL) cholesterol is a sensitive lipid marker for ...
Introduction: Although statin therapy is a powerful lipid-lowering strategy, only one-fifth of stati...
BACKGROUND: Treatments with ezetimibe/simvastatin (combined or alone) have been indicated as very pr...
Introduction: Although statin therapy is a powerful lipid-lowering strategy, only one-fifth of stati...
Plain language summary A statin is a type of medication that is used, with diet and exercise, to low...
BACKGROUND: Treatments with ezetimibe/simvastatin (combined or alone) have been indicated as very pr...
Introduction: Although statin therapy is a powerful lipid-lowering strategy, only one-fifth of stati...
PURPOSE: To explore the interaction between antiobesity drug, topiramate, and hypolipidemic drug, at...
Background Ezetimibe, as a cholesterol absorption inhibitor, has been shown protecting against ather...
Ezetimibe, as a cholesterol absorption inhibitor, has been shown protecting against atherosclerosis ...
Ezetimibe, as a cholesterol absorption inhibitor, has been shown protecting against atherosclerosis ...
Background: Many patients on statin therapy do not achieve recommended LDL cholesterol goals. They r...
Background: Dyslipidemia is a major cause of atherosclerosis and atherosclerosis induced conditions....
Patients with dyslipoproteinemia constitute the largest risk group for development of atherosclerosi...
Introduction: Although statin therapy is a powerful lipid-lowering strategy, only one-fifth of stati...
SummaryBackgroundOxidized low-density lipoprotein (LDL) cholesterol is a sensitive lipid marker for ...
Introduction: Although statin therapy is a powerful lipid-lowering strategy, only one-fifth of stati...
BACKGROUND: Treatments with ezetimibe/simvastatin (combined or alone) have been indicated as very pr...
Introduction: Although statin therapy is a powerful lipid-lowering strategy, only one-fifth of stati...
Plain language summary A statin is a type of medication that is used, with diet and exercise, to low...
BACKGROUND: Treatments with ezetimibe/simvastatin (combined or alone) have been indicated as very pr...
Introduction: Although statin therapy is a powerful lipid-lowering strategy, only one-fifth of stati...
PURPOSE: To explore the interaction between antiobesity drug, topiramate, and hypolipidemic drug, at...